PLAAT5
Basic information
Region (hg38): 11:63461404-63491194
Previous symbols: [ "HRASLS5" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PLAAT5 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 13 | 13 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 13 | 0 | 0 |
Variants in PLAAT5
This is a list of pathogenic ClinVar variants found in the PLAAT5 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-63463550-T-C | not specified | Uncertain significance (Dec 14, 2022) | ||
11-63463585-G-T | not specified | Uncertain significance (May 22, 2023) | ||
11-63466120-C-T | not specified | Uncertain significance (Dec 02, 2021) | ||
11-63466124-G-A | not specified | Uncertain significance (Jun 10, 2024) | ||
11-63466327-C-T | not specified | Uncertain significance (Nov 09, 2021) | ||
11-63466328-G-A | not specified | Uncertain significance (Aug 08, 2023) | ||
11-63468359-G-T | not specified | Uncertain significance (May 20, 2024) | ||
11-63468413-T-C | not specified | Uncertain significance (Dec 21, 2023) | ||
11-63468419-A-G | not specified | Uncertain significance (Aug 20, 2023) | ||
11-63468428-A-C | not specified | Uncertain significance (Jul 19, 2023) | ||
11-63468434-A-T | not specified | Uncertain significance (Dec 20, 2021) | ||
11-63488940-G-T | not specified | Uncertain significance (Jul 12, 2023) | ||
11-63490963-T-G | not specified | Uncertain significance (Mar 24, 2023) | ||
11-63491006-T-A | not specified | Uncertain significance (Feb 05, 2024) | ||
11-63491031-C-T | not specified | Uncertain significance (Mar 02, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PLAAT5 | protein_coding | protein_coding | ENST00000301790 | 6 | 29791 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00000212 | 0.481 | 125676 | 0 | 72 | 125748 | 0.000286 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.204 | 149 | 156 | 0.954 | 0.00000851 | 1774 |
Missense in Polyphen | 58 | 59.176 | 0.98012 | 706 | ||
Synonymous | 0.839 | 55 | 63.5 | 0.866 | 0.00000383 | 553 |
Loss of Function | 0.695 | 10 | 12.7 | 0.789 | 6.02e-7 | 152 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000899 | 0.000899 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000218 | 0.000217 |
Finnish | 0.0000924 | 0.0000924 |
European (Non-Finnish) | 0.0000616 | 0.0000615 |
Middle Eastern | 0.000218 | 0.000217 |
South Asian | 0.00118 | 0.00118 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: catalyzes N-acylation of phosphatidylethanolamine (PE) to generate N-Acylphosphatidylethanolamine (NAPE) a precursor of bioactive N-acylethanolamines, including the endocannabinoid anandamide. {ECO:0000269|PubMed:19000777}.;
- Pathway
- Metabolism of lipids;Metabolism;Glycerophospholipid biosynthesis;Phospholipid metabolism;Acyl chain remodelling of PE
(Consensus)
Recessive Scores
- pRec
- 0.0602
Intolerance Scores
- loftool
- rvis_EVS
- 1.48
- rvis_percentile_EVS
- 95.32
Haploinsufficiency Scores
- pHI
- 0.0466
- hipred
- N
- hipred_score
- 0.112
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0351
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Hrasls5
- Phenotype
Gene ontology
- Biological process
- N-acylphosphatidylethanolamine metabolic process
- Cellular component
- Molecular function
- N-acyltransferase activity